Quanterix (QTRX) is shedding several executives at its newly acquired subsidiary, Akoya Biosciences, as part of a cost-saving initiative expected to generate $2.8 million in annualized cash savings.
Severance-related expenses will be $3.3 million, the company said Friday in a regulatory filing.
Quanterix shares rose 5.4% in after-hours trading.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。